- Home
- RQI vs PRGO Comparison
RQI vs PRGO Comparison
Compare RQI & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RQI | PRGO |
|---|---|---|
| Founded | 2002 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | RQI | PRGO |
|---|---|---|
| Price | $12.65 | $10.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 484.2K | ★ 2.9M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | 8.20% | ★ 10.82% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.39 | $10.65 |
| 52 Week High | $13.39 | $29.08 |
Technical Indicators
Market Signals| Indicator | RQI | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 19.53 |
| Support Level | $12.14 | N/A |
| Resistance Level | $13.38 | $15.08 |
| Average True Range (ATR) | 0.19 | 0.59 |
| MACD | -0.08 | -0.44 |
| Stochastic Oscillator | 22.83 | 1.27 |
Price Performance
Historical ComparisonAbout RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.